ライフサイエンスコーパス: unvaccinated

1 accine exposure status (fully vaccinated and unvaccinated).

2 % among those vaccinated and 34% among those unvaccinated.

3 on, and a total of 8-12 million children are unvaccinated.

4 tients with a known vaccination history were unvaccinated.

5 1 (4%) had received 1 dose, and 5 (19%) were unvaccinated.

6 unvaccinated individuals were intentionally unvaccinated.

7 tients (46%) were female, and 340 (89%) were unvaccinated.

8 0 person-years; 95% CI, 18.7-26.6) among the unvaccinated.

9 cine twice, 1 was vaccinated once, and 1 was unvaccinated.

10 most half the cattle aged < 24 months remain unvaccinated.

11 the era after elimination were intentionally unvaccinated.

12 ) of the 77,607 included pregnant women were unvaccinated.

13 al mass campaigns, with a catch-up targeting unvaccinated 1- to 4-year-olds.

14 (>/=1 dose) (79.1 per 1000 person-years) vs unvaccinated (125.7 per 1000 person-years) females.

15 Among 4269 women, 1052 (24.6%) were unvaccinated, 2610 (61.1%) received 3 doses, 304 (7.1%)

16 lower among vaccinated (22.9%) compared with unvaccinated (31.6%) participants; aPR for those who ini

17 e cohort, the mothers of 55048 children were unvaccinated, 349 mothers were vaccinated in the first t

18 the rotavirus vaccine series compared to the unvaccinated (95% CI: 17%, 46%).

19 dent risk factors for measles included being unvaccinated (adjusted matched odds ratio [aMOR] 2.0, P

20 inconsistent with the numbers of cases among unvaccinated adolescents and adults in the new populatio

21 ccinees, whereas 2 cases were reported among unvaccinated adult SLSJ residents, and a third case in a

22 inate against hepatitis B virus (HBV) in all unvaccinated adults (including pregnant women) at risk f

23 upts transmission, reducing disease rates in unvaccinated adults.

24 A kidney-transplanted patient, unvaccinated against yellow fever (YF), developed high f

25 also declined in the post-vaccination era in unvaccinated age groups (<2 months [no cases in the post

26 otavirus infection and AGE in vaccinated and unvaccinated age groups within 1 year of introducing an

27 e the indirect protection afforded by PCV in unvaccinated age groups, including those in high-HIV-pre

28 outbreak of measles that originated from two unvaccinated Amish men in whom measles was incubating at

29 s rates were 3.3 per 100 000 person-years in unvaccinated and 1.3 per 100 000 person-years in vaccina

30 w-up was 41 years (IQR 32-49) for 83 421 BCG-unvaccinated and 44 years (41-46) for 297 905 vaccinated

31 y protective response is virtually absent in unvaccinated and BCG-vaccinated animals after challenge.

32 on vaccines and changes in the proportion of unvaccinated and fully vaccinated children.

33 Precancerous outcomes were compared between unvaccinated and HPV-vaccinated women born 1994-2005.

34 us macaques to receive BCG vaccine or remain unvaccinated and then undergo oral simian immunodeficien

35 ed to be involved in co-infection among both unvaccinated and vaccinated girls.

36 stillbirths per 100 000 pregnancy-days among unvaccinated and vaccinated women, respectively.

37 and immune people (who may be vaccinated or unvaccinated); and incorporates seasonal transmission an

38 ly vaccine-eligible pediatric travelers were unvaccinated, and antimicrobial-resistant infections wer

39 f tissue, respectively, compared to those in unvaccinated animals (P < 0.0001).

40 Seropositivity amongst unvaccinated animals born after the last outbreak indica

41 007), tended to be higher in vaccinated than unvaccinated anti-HBc-positive subjects (16 of 334 [4.8%

42 OBI frequency was lower in vaccinated than unvaccinated antibody to hepatitis B core antigen (anti-

43 ed-exposed (adjusted odds ratio [aOR], 2.2), unvaccinated (aOR, 3.7), underweight (aOR, 6.3), and too

44 HZV-vaccinated beneficiaries were matched to unvaccinated beneficiaries (primary analysis) and to HZV

45 als" comparing vaccinated beneficiaries with unvaccinated beneficiaries who had an outpatient health-

46 beneficiaries (primary analysis) and to HZV-unvaccinated beneficiaries who had received pneumococcal

47 hese hospital records in both girls and (HPV-unvaccinated) boys, with no relationship to the 2009 int

48 of having PRN(-) B. pertussis compared with unvaccinated case-patients (adjusted OR = 2.2; 95% confi

49 lder was underpowered because there were few unvaccinated cases and controls.

50 GPs of eligible but unvaccinated cases with comorbidities were mostly unawar

51 Among the 10 949 unvaccinated cases, 213 (1.9%) escaped mandatory vaccina

52 ly better for vaccinated cases compared with unvaccinated cases; however, no significant modification

53 e than unvaccinated immunocompetent mice and unvaccinated CD4-depleted mice remained persistently inf

54 k of measles in New York City began when one unvaccinated child returned home from Israel with measle

55 adult SLSJ residents, and a third case in an unvaccinated child who had stayed in the region during t

56 ly to have severe disease (9%; 5 of 56) than unvaccinated children (21%; 21 of 100; P = .05).

57 life is similar among PCV-vaccinated and PCV-unvaccinated children (3.26 and 3.34 years, respectively

58 relative reduction from 19.9% to 16.7%); PCV-unvaccinated children 6-8-year-old (40.5% reduction from

59 were similar to the observed changes in PCV-unvaccinated children and adults, but not among children

60 We studied 77 unvaccinated children before and 2 months after natural

61 Cumulatively, 573 rotavirus-unvaccinated children experienced 1418 rotavirus infecti

62 Herd immunity for unvaccinated children may occur in schools with vaccinat

63 ding global cause of diarrheal mortality for unvaccinated children under 5 years of age.

64 nation strategies and indirect protection of unvaccinated children will result in a large population

65 Comparing MMR-vaccinated with MMR-unvaccinated children yielded a fully adjusted autism ha

66 ndicators (eg, decreasing the number of DTP3-unvaccinated children) as well as program process indica

67 in California occurred at a high rate among unvaccinated children, particularly those infected durin

68 varicella program, although predominantly in unvaccinated children.

69 d caused serious illness, particularly among unvaccinated children.

70 with CAAP case status, among vaccinated and unvaccinated children.

71 s the hazard ratio comparing vaccinated with unvaccinated children.

72 r vaccination (95% CI: 27%, 35%) compared to unvaccinated children.

73 Study subjects were divided into unvaccinated cohorts (born before 1984) and vaccinated c

74 sAg-negative subjects declined from 160.7 in unvaccinated cohorts to 11.5 in vaccinated cohorts.

75 re 91 and 583 HZ cases in the vaccinated and unvaccinated cohorts, respectively, yielding an incidenc

76 iagnosis by 18% and of death by 20%, even in unvaccinated cohorts.

77 %, compared with cytology-based screening in unvaccinated cohorts.

78 Group 2 (n = 30) came from unvaccinated communities and Group 3 (n = 39) came from

79 o received PCV7 after 6 months and came from unvaccinated communities.

80 have received rotavirus vaccine (33/44 [73%] unvaccinated) compared with rotavirus-negative children

81 iral load in both vaccinated individuals and unvaccinated contact individuals they infect.

82 als, and readily transmitted B. pertussis to unvaccinated contacts.

83 rotection, by reducing transmission to their unvaccinated contacts.

84 esponse profile were protected compared with unvaccinated control animals (P = 0.026).

85 virus replication (P < .01) relative to the unvaccinated control animals.

86 onditions (in 255 [10%] of 2530 women in the unvaccinated control group and 201 [10%] of 2073 women i

87 Four women in the unvaccinated control group and three in the HPV vaccine

88 HPV vaccine group and 2836 women in the new unvaccinated control group were enrolled in the long-ter

89 PV vaccine group and 2530 women from the new unvaccinated control group were included in the analysis

90 licular helper CD4 T cells compared with the unvaccinated control group.

91 l group, and 6.2 years (5.5-6.9) for the new unvaccinated control group.

92 ived HPV vaccine and was replaced with a new unvaccinated control group.

93 Immunized and unvaccinated control participants underwent Plasmodium f

94 respectively, whereas it was 26/31 (81%) in unvaccinated control pups (P < 0.0001 for both groups ve

95 ays) and greater weight loss (>10%) than the unvaccinated controls and median survival times that wer

96 ques that were vaccinated with SIVmac239 and unvaccinated controls to determine whether the SIVsmE660

97 Unlike two of two unvaccinated controls, two of the four vaccinated monkey

98 t significantly different from those for the unvaccinated controls.

99 mRNA levels in challenged mice than those in unvaccinated controls.

100 wing RhCMV challenge compared to shedding in unvaccinated controls.

101 week 12 after the first vaccination and to 6 unvaccinated controls.

102 vaccine before the LTPS began, there were no unvaccinated controls.

103 a delay in time to treatment, compared with unvaccinated controls.

104 ts at age 2-4 years together with a group of unvaccinated controls.

105 ting these serotypes among vaccinated versus unvaccinated controls.

106 were significantly different from those for unvaccinated controls.

107 th detailed vaccination data, 574 cases were unvaccinated despite being vaccine eligible and 405 (70.

108 ed >/=1 mumps-containing vaccine, 1 (2%) was unvaccinated due to religious exemption, and 1 (2%) had

109 M. tuberculosis infection in both humans and unvaccinated experimental animal models.

110 emales (0% vs 0.5%, P > .99), and lower than unvaccinated females (0% vs 5.6%, P = .08).

111 was significantly lower in vaccinated versus unvaccinated females (0.5% vs 5.6%, P = .04).

112 ngeal HPV type was similar in vaccinated and unvaccinated females (19% vs 20%, P = .76).

113 ytology result was lower among vaccinated vs unvaccinated females (hazard ratio [HR], 0.64; 95% CI, 0

114 The decrease in 4vHPV-type prevalence among unvaccinated females suggests herd protection.

115 V) prevalence among HPV-16/18-vaccinated and unvaccinated Finnish male adolescents participating in c

116 against the risks of leaving young children unvaccinated for longer.

117 tions, a large connected cluster of children unvaccinated for measles will accumulate across Guinea,

118 ed in 2009, including 744 vaccinated and 294 unvaccinated girls (1993-1994) who provide a vaginal sel

119 vaccinated girls and 314,017 age-matched HPV-unvaccinated girls (cohort analyses); 11,817 girls with

120 , cervicovaginal samples from vaccinated and unvaccinated girls at age 18.5 years were typed for HPV6

121 This study was restricted to unvaccinated girls from the pre-vaccination cohort (n=52

122 ith multiple HPV types was more common among unvaccinated girls than vaccinated girls (9.2% vs. 3.7%)

123 accine efficacy for vaccinated girls, HE for unvaccinated girls, and the protective effectiveness (PE

124 ir NAb titers were 5- to 30-fold higher than unvaccinated girls.

125 (0.38; .29-.49), respectively, compared with unvaccinated girls.

126 ces were detected between the vaccinated and unvaccinated groups in risk for inpatient visits (rate r

127 women and 3.93 per 1,000 person-years in the unvaccinated (hazard ratio = 1.01, 95% confidence interv

128 orter length of ICU stay than those who were unvaccinated (hazard ratio for discharge, 1.84; 95% conf

129 n-label, single-site study in 103 previously unvaccinated healthy adults age >=18 to <=60 years old t

130 a vaccinated with 6MHP to that of a group of unvaccinated historical controls.

131 type colonization reduction, including among unvaccinated HIV-infected women.

132 en strains that cause more severe disease in unvaccinated hosts.

133 (968 with IIV3 and 900 with IPV) with 10 813 unvaccinated household contacts.

134 was febrile acute respiratory illness in an unvaccinated household member of a vaccine study partici

135 The infection probability of unvaccinated household members in vaccinated households

136 e predict that the infection probability for unvaccinated household members would only be reduced by

137 Thirty-seven percent of the unvaccinated households with HBsAg carriers were aware o

138 mice had significantly faster clearance than unvaccinated immunocompetent mice and unvaccinated CD4-d

139 y of herpes zoster (HZ), particularly in the unvaccinated immunocompetent population, are needed to a

140 y of herpes zoster (HZ), particularly in the unvaccinated, immunocompetent population, are needed to

141 children's health and safety that remaining unvaccinated in a predominantly vaccine-protected commun

142 rth outcomes for IIV in pregnancy with women unvaccinated in pregnancy using Cox proportional hazard

143 s significantly reduced in vaccinated versus unvaccinated individuals (0.11% v 1.61%; Padj = .008), c

144 Unvaccinated individuals born in 1995 had a reduced odds

145 ccine-specific and cross-protective types in unvaccinated individuals born in 1995.

146 nce in disease burden between vaccinated and unvaccinated individuals can be ascribed to the vaccine-

147 A total of 1,414 unvaccinated individuals had baseline T-cell measurement

148 Compared with unvaccinated individuals in the current and 5 prior seas

149 However, the cases of Hib were either in unvaccinated individuals or children who had not yet rec

150 8 of these outbreaks from 59% through 93% of unvaccinated individuals were intentionally unvaccinated

151 ge of group A meningococci in vaccinated and unvaccinated individuals, demonstrating the vaccine's ab

152 In unvaccinated individuals, induced protein 10 (IP-10), in

153 tries was enhanced by indirect protection of unvaccinated individuals, mediated by reduced nasopharyn

154 cell function and phenotype in 52 previously unvaccinated individuals.

155 lower but still significantly higher than in unvaccinated individuals.

156 and 60 (1%) of 4121 IPV-allocated household unvaccinated individuals.

157 d odds of case status between vaccinated and unvaccinated individuals; VE estimates were calculated a

158 The propensity to infect unvaccinated infants and those at risk for insufficient

159 Protection of unvaccinated infants requires avoidance of travel to end

160 The numbers would be substantially higher if unvaccinated infants, adolescents, and adult populations

161 nths of age had a lower risk of measles than unvaccinated infants.

162 senteric lymph nodes of vaccinated infected, unvaccinated infected, and uninfected macaques identifie

163 n vaccinated (IR 1.14, 95% CI 0.75-1.74) and unvaccinated (IR 1.78, 95% CI 1.68-1.88) individuals dur

164 Three vaccinated and 10 unvaccinated laboratory-confirmed cases occurred over ob

165 ositively correlated with plasma viremia and unvaccinated macaques had increased plasma cells and pla

166 pe (Env) sequences from 49 vaccinated and 15 unvaccinated macaques were compared to each other, we we

167 The prevalence of 4vHPV genotypes among 511 unvaccinated male subjects was significantly lower in th

168 t of the program impact on HPV prevalence in unvaccinated male subjects.

169 HPV infection and potential herd immunity in unvaccinated males has resulted in considerable controve

170 Oropharyngeal HPV-16 prevalence in unvaccinated males was similar to vaccinated females (0%

171 assessed by comparing the attack rates among unvaccinated members between high and low vaccine covera

172 vaccinated with HZ vaccine and three matched unvaccinated members were included.

173 s significantly reduced in vaccinated versus unvaccinated men (0.0% v 2.13%; Padj = .007).

174 curred in 26 vaccinated men (6.0%) versus 25 unvaccinated men (5.8%), with an adjusted relative risk

175 These data suggest that unvaccinated men may have benefited from herd protection

176 types, and time to subsequent GW event among unvaccinated men.

177 o longitudinal data on genital infections in unvaccinated men.

178 ction against vaginal infection than seen in unvaccinated mice (P < .005).

179 arance of bacteria from the lung compared to unvaccinated mice.

180 intravaginal transmissions in vaccinated and unvaccinated monkeys.

181 reakthrough compared with T/F Envs from four unvaccinated monkeys.

182 irth was 51% less likely among vaccinated vs unvaccinated mothers (aHR, 0.49; 95% confidence interval

183 accinated mothers, and naive infants born to unvaccinated mothers were infected with B. pertussis at

184 hospital stays compared with infants born to unvaccinated mothers, after adjustment for chronological

185 Compared with infants of unvaccinated mothers, PT, FHA, and FIMs antibodies were

186 unit admission compared with infants born to unvaccinated mothers.

187 usted hazard ratios (aHRs) in vaccinated and unvaccinated mothers.

188 ikely to experience stillbirth compared with unvaccinated mothers.

189 Previously vaccinated (n = 395) or unvaccinated (n = 149) male adolescents were enrolled in

190 Unvaccinated neonates and infants </=42 days old may ind

191 89.3% was seen in all age groups, including unvaccinated neonates and young infants.

192 ted with a 41% increase in the odds of being unvaccinated (odds ratio (OR) = 1.41, 95% confidence int

193 an adenovirus type 7 (HAdV-7) occurred among unvaccinated officer candidates attending initial milita

194 8 years (range: 3 months-75 years); 87% were unvaccinated or had an unknown vaccination status.

195 Unvaccinated or previously uninfected persons are suscep

196 ots, especially if travelers were previously unvaccinated or returning to US communities with heterog

197 ce that this outbreak most likely arose from unvaccinated or under-vaccinated canines, not from a nov

198 substantial proportions (range, 24%-45%) of unvaccinated or undervaccinated individuals.

199 eported measles cases, of which 57% occurred unvaccinated or undervaccinated persons, with an unknown

200 Participants were either unvaccinated or vaccinated with 1 of 4 vaccines: Vi-poly

201 ver, these estimates are based on studies in unvaccinated or whole-cell pertussis-vaccinated children

202 , especially if the travelers are previously unvaccinated or will return to US communities with heter

203 together more often than expected among both unvaccinated (p=0.002) and vaccinated girls (p<0.001).

204 th rotavirus-negative children (81/136 [59%] unvaccinated) (P= .002).

205 e same decreases were also significant among unvaccinated participants (adjusted odds ratios, 0.44; [

206 s who received Vi-PS or Vi-TT shed less than unvaccinated participants (odds ratio [OR], 0.34; 95% co

207 compared HPV prevalence among vaccinated and unvaccinated participants and determined adjusted preval

208 paring disease outcomes in vaccinated versus unvaccinated participants via multivariable logistic reg

209 We compared the proportion of vaccinated and unvaccinated participants who were seropositive for the

210 % [95% confidence interval, 32%-38%]) of 911 unvaccinated participants, of whom 100 (31%) seroconvert

211 for influenza virus among vaccinated versus unvaccinated participants.

212 tained at 7 months from 42 vaccinated and 24 unvaccinated participants.

213 test positivity among vaccinated compared to unvaccinated participants.

214 he odds of influenza among vaccinated versus unvaccinated participants.

215 tive for influenza virus among vaccinated vs unvaccinated participants.

216 ped coughing significantly more rapidly than unvaccinated patients (adjusted hazard ratio, 1.7; 95% C

217 human papillomavirus (HPV) among previously unvaccinated patients aged 9-26 years; and consideration

218 Each vaccinated patient was matched to five unvaccinated patients on age, sex, and dialysis duration

219 for influenza among vaccinated patients and unvaccinated patients, adjusting for confounders.

220 pare disease severity between vaccinated and unvaccinated patients, adjusting for timing of antiviral

221 atients were matched 1:1 by sex and age with unvaccinated patients.

222 e of PHN was compared between vaccinated and unvaccinated -patients.

223 ot have any contact with immunosuppressed or unvaccinated people for the duration of faecal shedding

224 y; vaccination protected both vaccinated and unvaccinated people in those clusters.

225 re maintained by poor vaccine responders and unvaccinated people.

226 [95% CI, 20.90-22.20] for the vaccinated and unvaccinated periods; adjusted rate ratio, 0.90 [95% CI,

227 in vaccinated persons and herd protection in unvaccinated persons is uncertain.

228 n for postexposure prophylaxis in previously unvaccinated persons taking any antimalarial drug.

229 e-serotype IPD in vaccinated children and in unvaccinated persons.

230 epidemiology data among an immunocompetent, unvaccinated population measure real-world disease burde

231 mpaigns targeting varying proportions of the unvaccinated population up to 15 years of age.

232 arison of the vaccinated population with the unvaccinated population was 0.51 (95% confidence interva

233 s is due to increasing HPV prevalence in the unvaccinated population.

234 cines (PCV) can indirectly reduce illness in unvaccinated populations is not known.

235 pected and confirmed cases in vaccinated and unvaccinated populations were estimated with negative bi

236 isease changes following PCV introduction in unvaccinated populations, updating the previous systemat

237 % (95% CI 55-59) in vaccinated compared with unvaccinated populations, with some heterogeneity observ

238 is virus has stalled, and MV still threatens unvaccinated populations.

239 l serotypes can also prevent transmission to unvaccinated populations.

240 dverse birth outcomes between vaccinated and unvaccinated pregnancies.

241 regnancy a vaccination was given compared to unvaccinated pregnancies.

242 We investigated whether unvaccinated pregnant women were clustered geographicall

243 In conclusion, unvaccinated pregnant women were clustered geographicall

244 ntified 5 clusters with a high prevalence of unvaccinated pregnant women.

245 sk of an adverse birth outcome compared with unvaccinated pregnant women: preterm births (HR, 1.10 [9

246 Weighted seroprevalence was estimated among unvaccinated, sexually experienced 18-59 year-old MSM, M

247 3285 adults: 1217 statin nonusers (37%), 903 unvaccinated statin nonusers (27%), 847 vaccinated stati

248 , 847 vaccinated statin users (26%), and 318 unvaccinated statin users (10%).

249 l [CI], 87%-97%) vs 37% (95% CI, 24%-51%) in unvaccinated students.

250 who received the recommended 2 doses and 52 unvaccinated students.

251 sed a cohort design including vaccinated and unvaccinated study participants.

252 ng HPV-16/18-vaccinated (4.1%) compared with unvaccinated subjects (10.1%) (P = .01).

253 = 0.072), and was higher in vaccinated than unvaccinated subjects seropositive for both antibody to

254 A total 1479 unvaccinated subjects were included.

255 ferred reasonably across both vaccinated and unvaccinated subjects, with infections resulting from va

256 occurrence of OBI than natural infections in unvaccinated subjects.

257 lity following either HPV vaccination or, if unvaccinated, the first missed opportunity for HPV vacci

258 ar risk periods following vaccination and in unvaccinated time periods.

259 ed primarily through international travel by unvaccinated travelers.

260 sles outbreaks; the percentage of previously-unvaccinated travelers; and the percentage of travelers

261 ed by HPV vaccine and 33 nonvaccine types in unvaccinated US adults aged 18 to 59 years from 2009 to

262 The odds of being unvaccinated were greater for Black women (OR = 1.58, 95

263 All village residents, vaccinated and unvaccinated, were monitored for signs and symptoms of i

264 ior doses (38%; P = .009) or those currently unvaccinated with 1-2 prior doses (10%; P < .001).

265 scenario using rhesus monkeys vaccinated or unvaccinated with the rVSV-ZEBOV vaccine.

266 mated from immunocompetent adults >=50 years unvaccinated with zoster vaccine live who had incident H

267 from immunocompetent adults aged >=50 years unvaccinated with zoster vaccine live who had incident H

268 V among vaccinated WLWH was lower than among unvaccinated WLWH (2.3 vs 6.0/100PY).

269 nd unvaccinated women without HIV as well as unvaccinated WLWH.

270 rates of persistent qHPV were lower than in unvaccinated WLWH.

271 among those who self-reported vaccination or unvaccinated women (1.76% and 15.0%, respectively).

272 men (4.2%) experienced PHN, compared with 75 unvaccinated women (10.4%), with an adjusted relative ri

273 olled for differences between vaccinated and unvaccinated women and influenza virus circulation.

274 Sexually active unvaccinated women and men aged 16 to 25 years old were

275 atios for preterm birth in vaccinated versus unvaccinated women and the associated sample size requir

276 kinetics of maternal pertussis antibodies in unvaccinated women and their infants (group A; 86 mother

277 11, -16, and -18) among all, vaccinated, and unvaccinated women at waves 1, 2, and 3, adjusted for di

278 Unvaccinated women born between 1975 and 1990 were predi

279 The 4vHPV-type prevalence was 7.4% among unvaccinated women compared with 1.7%, 1.0%, and 1.0% am

280 100% (95% CI 89.2-100.0); 34 (1.5%) of 2233 unvaccinated women had a CIN2+ outcome compared with non

281 vaccinated infants, and the control group of unvaccinated women had highest pertussis-specific respon

282 vaccinated infants, and the control group of unvaccinated women had highest PT-specific responses, pe

283 The proportion of unvaccinated women ranged from 57% to 75% within cluster

284 statistically significantly less likely than unvaccinated women to have an infant born preterm during

285 eness for confirmed vaccinated compared with unvaccinated women was 95.93% (95% confidence interval [

286 vulvar HPV16/18 among HPV vaccinated versus unvaccinated women was calculated and compared to the ce

287 The mean (SD) ages of vaccinated and unvaccinated women were 31.6 (5.2) and 30.4 (5.6) years,

288 e rates to published rates in vaccinated and unvaccinated women without HIV as well as unvaccinated W

289 disease within vaccinated women without HIV, unvaccinated women without HIV, and vaccinated WLWH: 0.1

290 om a population-based case-control study for unvaccinated women, and using a microsimulation model fo

291 tiveness in a community setting, and >30% in unvaccinated women, providing evidence of herd protectio

292 CIN2+ over 7 years of follow-up compared to unvaccinated women, resulting in a VE of 57.9% (95% CI,

293 nce ratio) for HPV among all women and among unvaccinated women.

294 en self-reporting vaccination, and 1893 from unvaccinated women.

295 to enhance current cervical screening among unvaccinated women.

296 , and from 32.5% to 22.0% (32.3% decline) in unvaccinated women.

297 baseline differences between vaccinated and unvaccinated women.

298 incidence of cervical dysplasia compared to unvaccinated women.

299 95% CI, .30-.45]) vaccine doses, compared to unvaccinated women.

300 An unvaccinated, young, female patient with measles confirm